NTHI
NeOnc Technologies Holdings, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:35:45 PM EST
3.27USD-21.394%(-0.89)360,086
Pre-marketNov 19, 2026 9:25:30 AM EST
4.20USD+0.962%(+0.04)
NTHI News
NeOnc Technologies Announces FDA Rescheduled NEO212 End-of-Phase 1 Type B Meeting to November 23 ·
GlobeNewswire Inc.+1 source
NeOnc Reports Additional Partial Response in Phase 2a Study of Intranasal NEO100 ·
GlobeNewswire Inc.+1 source
Neonc Technologies CEO Amir Heshmatpour buys $294.5K shares ·
Investing.com
Neonc Technologies CEO buys $150,501 in stock ·
Investing.com
NeOnc Showcases Two Brain Cancer Drug Programs at SNO as FDA Meetings Approach ·
GlobeNewswire Inc.
NeonC Technologies CMO Thomas Chen buys $20,000 in company stock ·
Investing.com
FDA Meeting Could Put NeOnc's NEO100 Experimental Brain Cancer Drug on Faster Track ·
GlobeNewswire Inc.
Neonc Technologies CEO Amir Heshmatpour buys $38,600 in stock ·
Investing.com
NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues ·
GlobeNewswire Inc.
Neonc Technologies CEO buys $230,510 in company stock ·
Investing.com
NeOnc Technologies Holdings GAAP EPS of -$0.28 misses by $0.09 ·
Seeking Alpha
NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress ·
GlobeNewswire Inc.+1 source